On July 18, 2025, GSR, a key player in crypto capital markets, announced a $100 million investment and strategic partnership with MEI Pharma, Inc. (NASDAQ:MEIP). This collaboration aims to position Litecoin (LTC) as a treasury asset, with GSR acting as a strategic advisor and digital asset treasury manager. GSR will collaborate with Litecoin's creator, Charlie Lee, who will join MEI's Board of Directors, alongside a GSR representative. This partnership aligns with MEI's new mission and follows its review of strategic alternatives. Lee emphasized Litecoin's decade-long stability and its integration into retail and payment systems. The partnership marks a significant step in bridging public markets with crypto innovation, enhancing institutional confidence in LTC$ETH
